Literature DB >> 1909536

The natural history of untreated phenylketonuria over 20 years.

D B Pitt1, D M Danks.   

Abstract

Fifty-one adults with untreated phenylketonuria (PKU), have been reviewed after a 20 year interval, at ages ranging from 28.8 to 71.8 years. Five died of causes unrelated to PKU. Three severely affected individuals had shown a progressive loss of motor function and three had developed epilepsy, bringing the total with this problem to 12. No loss of abilities was apparent in 41 patients. Other health problems, including cataracts, were not frequent. Serum phenylalanine levels had decreased over the 20 year period. Untreated PKU does not generally cause progressive loss of abilities during adult life.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909536     DOI: 10.1111/j.1440-1754.1991.tb00384.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  12 in total

Review 1.  Rare diseases and the assessment of intervention: what sorts of clinical trials can we use?

Authors:  B Wilcken
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

2.  Outcomes of phenylketonuria with relevance to follow-up.

Authors:  F J van Spronsen; A Bélanger-Quintana
Journal:  JIMD Rep       Date:  2011-06-22

3.  Vitamin B12 deficiency in adolescents and young adults with phenylketonuria.

Authors:  W B Hanley; A S Feigenbaum; J T Clarke; W E Schoonheyt; V J Austin
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

4.  Phenylketonuria: treatment in adolescence and adult life.

Authors:  D P Brenton; A C Tarn; J C Cabrera-Abreu; M Lilburn
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

5.  Characterization of phenylalanine hydroxylase alleles in untreated phenylketonuria patients from Victoria, Australia: origin of alleles and haplotypes.

Authors:  S J Ramus; E P Treacy; R G Cotton
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

Review 6.  Phenylketonuria does not cause cataracts.

Authors:  D B Pitt; J O'Day
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

7.  High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU.

Authors:  Sankar Surendran; Gerald A Campbell; Stephen K Tyring; Kimberlee Matalon; J David McDonald; Reuben Matalon
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

8.  Phenylalanine sensitive K562-D cells for the analysis of the biochemical impact of excess amino acid.

Authors:  Yoshitami Sanayama; Akio Matsumoto; Naoki Shimojo; Yoichi Kohno; Haruaki Nakaya
Journal:  Sci Rep       Date:  2014-11-06       Impact factor: 4.379

Review 9.  Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.

Authors:  Deborah A Bilder; J Kay Noel; Erin R Baker; William Irish; Yinpu Chen; Markus J Merilainen; Suyash Prasad; Barbara J Winslow
Journal:  Dev Neuropsychol       Date:  2016-11-02       Impact factor: 2.253

Review 10.  Newborn screening 50 years later: access issues faced by adults with PKU.

Authors:  Susan A Berry; Christine Brown; Mitzie Grant; Carol L Greene; Elaina Jurecki; Jean Koch; Kathryn Moseley; Ruth Suter; Sandra C van Calcar; Judy Wiles; Stephen Cederbaum
Journal:  Genet Med       Date:  2013-03-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.